Mind Medicine (MindMed) Inc.
CBOE CATotal Valuation
Mind Medicine (MindMed) Inc. carries a market capitalization of 1.05B, placing it among publicly traded companies globally. Its enterprise value stands at -168.68M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.05B |
| Enterprise Value | -168.68M |
Share Statistics
Mind Medicine (MindMed) Inc. currently has 76.77M shares outstanding.
| Shares Outstanding | 76.77M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
Mind Medicine (MindMed) Inc. maintains a current ratio of 3.30, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 30.92, indicating elevated leverage, while an interest coverage ratio of -31.05 demonstrates limited ability to service its debt obligations.
| Current Ratio | 3.30 |
| Quick Ratio | 3.20 |
| Debt / Equity | 30.92 |
| Debt / EBITDA | -0.27 |
| Interest Coverage | -31.05 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -60.39 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Mind Medicine (MindMed) Inc.'s stock has gained approximately 249.76526% over the past 52 weeks. The 50-day moving average sits at 9.88, while the 200-day moving average is 6.11.
| Beta (5Y) | N/A |
| 52-Week Price Change | 249.76526% |
| 50-Day Moving Average | 9.88 |
| 200-Day Moving Average | 6.11 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -151.19M, while operating income came in at -151.19M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -151.19M |
| Pretax Income | -168.10M |
| Net Income | -168.10M |
| EBITDA | -151.19M |
| EBIT | -151.19M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
Mind Medicine (MindMed) Inc. holds 209.07M in cash and equivalents against 40.39M in total debt, resulting in a net debt position of 20.43M. Total book value stands at -532.24M, with working capital of 150.43M providing operational flexibility.
| Cash & Cash Equivalents | 209.07M |
| Total Debt | 40.39M |
| Net Debt | 20.43M |
| Equity (Book Value) | -532.24M |
| Book Value Per Share | N/A |
| Working Capital | 150.43M |
Cash Flow
Mind Medicine (MindMed) Inc. produced -113.94M in operating cash flow over the past twelve months.
| Operating Cash Flow | -113.94M |
| Capital Expenditures | N/A |
| Free Cash Flow | -113.94M |
| FCF Per Share | N/A |
Stock Splits
Mind Medicine (MindMed) Inc.'s most recent stock split took place on August 29, 2022 with a 15:1 split ratio.
| Last Split Date | 8/29/2022 |
| Split Ratio | 15:1 |
Scores
Mind Medicine (MindMed) Inc. posts an Altman Z-Score of -4.90, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -4.90 |